Recent

% | $
Quotes you view appear here for quick access.

Navidea Biopharmaceuticals, Inc Message Board

  • chrism.tarr chrism.tarr Sep 11, 2012 12:27 AM Flag

    Well We Now Know They Didn't Use The Wrong Comparator

    The shorts now have nothing..... I don't know why the FDA is stuck in the 1920s and have to make NAVB go through this entire process. I don't understand why they couldn't approve the drug contingent on getting the manufacturing taken care of. That would be too efficient. They want the money of a resubmission no matter what is costs a small company trying to help people.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
NAVB
1.68+0.0300(+1.82%)Mar 27 4:06 PMEDT